|  | Placebo | ARB | ARB + HCT |
---|---|---|---|---|
Systolic blood pressure (mmHg) | RS | 143 (4) | 135 (3)†| 125 (3)†‡ |
LS | 136 (3)* | 128 (3)*†| 121 (2)†‡ | |
Diastolic blood pressure (mmHg) | RS | 86 (2) | 80 (2)†| 75 (1)†‡ |
LS | 83 (1)* | 78 (1)†| 74 (1)†‡ | |
Plasma potassium concentration (mmol/l) | RS | 4.3 ± 0.1 | 4.4 ± 0.1 | 4.0 ± 0.1†‡ |
LS | 4.3 ± 0.1 | 4.5 ± 0.1†| 4.0 ± 0.1†‡ | |
24 h sodium excretion (mmol/day) | RS | 200 ± 10 | 197 ± 11 | 193 ± 11 |
LS | 89 ± 10* | 92 ± 8* | 93 ± 8* | |
Creatinine clearance (ml/min) | RS | 85 (73–98) | 90 (77–106) | 81 (69–95)‡ |
LS | 80 (67–94) | 79 (67–93)* | 72 (61–85)* | |
Proteinuria (g/day) | RS | 3.4 (2.6–4.3) | 2.3 (1.8–3.0)†| 1.3 (1.0–1.7)†‡ |
LS | 2.3 (1.7–3.1)* | 1.3 (0.9–1.7)†* | 0.9 (0.6–1.2)*†‡ | |
Active plasma renin concentration (ng AI/ml x h) | RS | 15 (12–18) | 33 (23–45)†| 64 (47–87)†‡ |
LS | 19 (15–23) | 51 (38–70)*†| 130 (103–163)*†‡ | |
Plasma aldosterone concentration (ng/l) | RS | 66 (48–91) | 57 (41–79) | 96 (74–125)‡ |
LS | 106 (73–152) | 113 (86–149)* | 164 (129–207)*†‡ | |
Aldosterone-to-renin ratio (ng/ng AI × h) | RS | 19 (13–26) | 7 (4–11)†| 6 (4–9)†|
LS | 22 (14–32) | 9 (6–13)†| 5 (4–7)†‡ |